Franck Meslin
Impact in
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
-
- Neurological diseases and metabolism
Papers in
-
- Cell death mechanisms and regulation 4
- Protein Degradation and Inhibitors 2
- Prion Diseases and Protein Misfolding 2
- Ubiquitin and proteasome pathways 2
- Oncology 6
- Cancer Immunotherapy and Biomarkers 3
- Cancer-related Molecular Pathways 2
- Co-authors
- Salem Chouaı̈b (9 shared papers)Abdelali Jalil (5 shared papers)Ahmed Hamaï (5 shared papers)Maryam Mehrpour (4 shared papers)Catherine Richon (3 shared papers)Houssem Benlalam (2 shared papers)Jérôme Thiery (3 shared papers)Yann Lécluse (2 shared papers)
- Journals
- Annals of Oncology (2 papers)Cancer Research (2 papers)Journal of Biological Chemistry (1 paper)Clinical Immunology (1 paper)Oncogene (1 paper)
- Partner nations
- FranceChinaUnited States
In The Last Decade
Franck Meslin
10 papers receiving 329 citations
Peers
Comparison fields: 5 of 63
- Immunology 103
- Neurology 37
- Oncology 115
- Molecular Biology 204
- Cancer Research 38
Countries citing papers authored by Franck Meslin
This map shows the geographic impact of Franck Meslin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franck Meslin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franck Meslin more than expected).
Fields of papers citing papers by Franck Meslin
This network shows the impact of papers produced by Franck Meslin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franck Meslin. The network helps show where Franck Meslin may publish in the future.
Co-authors
The 25 scholars most cited alongside Franck Meslin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 61 | |
| 2 | 2009 | 56 | |
| 3 | 2007 | 53 | |
| 4 | 2006 | 42 | |
| 5 | 2007 | 36 | |
| 6 | 2007 | 34 | |
| 7 | 2007 | 32 | |
| 8 | 2011 | 7 | |
| 9 | 2008 | 7 | |
| 10 | 2008 | 4 |
About Franck Meslin
Franck Meslin is a scholar working on Molecular Biology, Oncology, Immunology, Neurology and Cell Biology, having authored 10 papers that have together received 332 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (4 papers), Cell death mechanisms and regulation (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Protein Degradation and Inhibitors (2 papers), Cancer-related Molecular Pathways (2 papers), Prion Diseases and Protein Misfolding (2 papers), Ubiquitin and proteasome pathways (2 papers) and Neurological diseases and metabolism (1 paper). The work is most often cited by research in Immunology (103 citations), Neurology (37 citations), Oncology (115 citations), Molecular Biology (204 citations) and Cancer Research (38 citations). Franck Meslin has collaborated with scholars based in France, China and United States. Frequent co-authors include Salem Chouaı̈b, Abdelali Jalil, Ahmed Hamaï, Maryam Mehrpour, Catherine Richon, Houssem Benlalam, Jérôme Thiery, Yann Lécluse, Florence Faure and Nathalie Cahuzac. Their work appears in journals such as Annals of Oncology, Cancer Research, Journal of Biological Chemistry, Clinical Immunology and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.